Marco Investment Management LLC Purchases 120 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Marco Investment Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,665 shares of the healthcare conglomerate’s stock after purchasing an additional 120 shares during the period. UnitedHealth Group accounts for approximately 1.9% of Marco Investment Management LLC’s holdings, making the stock its 15th largest holding. Marco Investment Management LLC’s holdings in UnitedHealth Group were worth $21,437,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. China Universal Asset Management Co. Ltd. raised its stake in UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after buying an additional 1,857 shares during the period. Quent Capital LLC grew its holdings in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the period. EntryPoint Capital LLC bought a new position in UnitedHealth Group during the first quarter worth about $75,000. Lavaca Capital LLC boosted its holdings in shares of UnitedHealth Group by 4.3% during the first quarter. Lavaca Capital LLC now owns 3,254 shares of the healthcare conglomerate’s stock worth $1,610,000 after acquiring an additional 135 shares during the period. Finally, Silvercrest Asset Management Group LLC boosted its holdings in shares of UnitedHealth Group by 40.9% during the first quarter. Silvercrest Asset Management Group LLC now owns 25,170 shares of the healthcare conglomerate’s stock worth $12,452,000 after acquiring an additional 7,308 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $590.87 on Friday. The firm’s 50-day moving average price is $582.63 and its 200-day moving average price is $552.95. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $543.77 billion, a P/E ratio of 38.49, a P/E/G ratio of 1.75 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on UNH shares. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. KeyCorp began coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Truist Financial restated a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.